Do you have regular migraine headaches? If so, you’ve got a lot of company. Nearly 1 in every 3 people worldwide suffer from a headache disorder, affecting almost 3 billion people, researchers will report in the December issue of The Lancet Neurology. It’s especially bad for women, who experience more than double the lifetime headache-related health problems than men, researchers found. “Women experience significantly higher levels of headache-related disability because they have headaches more frequently and for longer durations than men,” investigator Yvonne Xu, a research scientist at the University of Washington’s Institute for Health Metrics and Evaluation, said in a news release. “Recognizing this is essential for improving how we prevent and manage headache disorders worldwide,” Xu added. For the study, researchers analyzed data on nearly 42,000 people from 18 countries to create an estimate of the global health burden caused by headaches in the year 2023. Results showed that headache disorders ranked sixth among all causes of disability, with a rate of 542 years lived with disability for every 100,000 people. That statistic captures the total time people spend living with health problems that limit their daily activities and well-being. The disability burden of headache disorders was more than twice as high for women – 740 years lived with disability per 100,000 women compared to 364 per 100,000 men, the study said. Across…  read on >  read on >

Do you have regular migraine headaches? If so, you’ve got a lot of company. Nearly 1 in every 3 people worldwide suffer from a headache disorder, affecting almost 3 billion people, researchers will report in the December issue of The Lancet Neurology. It’s especially bad for women, who experience more than double the lifetime headache-related health problems than men, researchers found. “Women experience significantly higher levels of headache-related disability because they have headaches more frequently and for longer durations than men,” investigator Yvonne Xu, a research scientist at the University of Washington’s Institute for Health Metrics and Evaluation, said in a news release. “Recognizing this is essential for improving how we prevent and manage headache disorders worldwide,” Xu added. For the study, researchers analyzed data on nearly 42,000 people from 18 countries to create an estimate of the global health burden caused by headaches in the year 2023. Results showed that headache disorders ranked sixth among all causes of disability, with a rate of 542 years lived with disability for every 100,000 people. That statistic captures the total time people spend living with health problems that limit their daily activities and well-being. The disability burden of headache disorders was more than twice as high for women – 740 years lived with disability per 100,000 women compared to 364 per 100,000 men, the study said. Across…  read on >  read on >

There’s no clear evidence linking acetaminophen use during pregnancy with developmental issues like autism or ADHD, two major evidence reviews have concluded. Any increased risk observed in dozens of studies tended to cancel out when researchers adjusted for other potential factors, or when they compared between siblings to validate their findings, both evidence reviews found. “Existing evidence does not show a clear link between in utero exposure to (acetaminophen) and autism and ADHD in offspring,” concluded researchers in The BMJ. These reviews follow an exhortation by President Donald Trump in September that women avoid using acetaminophen, sold over the counter as Tylenol, during pregnancy due to increased risk of autism. “Tylenol during pregnancy can be associated with a very increased risk of autism,” Trump claimed, according to The Associated Press. “I want to say it like it is, don’t take Tylenol,” Trump also said, encouraging women to “just fight like hell not to take it.” His comments run counter to guidelines from medical societies like the American College of Obstetricians & Gynecologists (ACOG). It says, “Acetaminophen is well studied and proven to be safe for use in pregnancy, and is one of the only medicines available to pregnant women for pain relief and treatment of headaches and fevers.” For an extensive review published Monday in The BMJ, researchers analyzed data from 40 studies included in…  read on >  read on >

There’s no clear evidence linking acetaminophen use during pregnancy with developmental issues like autism or ADHD, two major evidence reviews have concluded. Any increased risk observed in dozens of studies tended to cancel out when researchers adjusted for other potential factors, or when they compared between siblings to validate their findings, both evidence reviews found. “Existing evidence does not show a clear link between in utero exposure to (acetaminophen) and autism and ADHD in offspring,” concluded researchers in The BMJ. These reviews follow an exhortation by President Donald Trump in September that women avoid using acetaminophen, sold over the counter as Tylenol, during pregnancy due to increased risk of autism. “Tylenol during pregnancy can be associated with a very increased risk of autism,” Trump claimed, according to The Associated Press. “I want to say it like it is, don’t take Tylenol,” Trump also said, encouraging women to “just fight like hell not to take it.” His comments run counter to guidelines from medical societies like the American College of Obstetricians & Gynecologists (ACOG). It says, “Acetaminophen is well studied and proven to be safe for use in pregnancy, and is one of the only medicines available to pregnant women for pain relief and treatment of headaches and fevers.” For an extensive review published Monday in The BMJ, researchers analyzed data from 40 studies included in…  read on >  read on >

Vitamin D might help people with heart disease avoid a heart attack, if it’s provided in a dose tailored to you by a doctor, a new study says. Folks provided vitamin D reduced their risk by more than half, researchers reported Sunday at the American Heart Association’s annual meeting in New Orleans. But there’s a catch — people weren’t downing supplements on their own, but taking custom doses designed to optimize the vitamin D levels in their blood, researchers said. “We encourage people with heart disease to discuss vitamin D blood testing and targeted dosing with their health care professionals to meet their individual needs,” lead researcher Heidi May, an epidemiologist at Intermountain Health in Salt Lake City, said in a news release. For the study, researchers recruited 630 adults with heart disease who were treated at Intermountain Medical Center between April 2017 and May 2023. More than 85% of participants began the study with vitamin D levels below 40ng/mL, a level many experts consider too low for best health, researchers said. Participants were around 63 years old on average and 48% had a previous heart attack. One group was assigned to take tailored doses of vitamin D to bring their blood levels up, and the rest received care as normal. “Previous clinical trial research on vitamin D tested the potential impact of the same…  read on >  read on >

Vitamin D might help people with heart disease avoid a heart attack, if it’s provided in a dose tailored to you by a doctor, a new study says. Folks provided vitamin D reduced their risk by more than half, researchers reported Sunday at the American Heart Association’s annual meeting in New Orleans. But there’s a catch — people weren’t downing supplements on their own, but taking custom doses designed to optimize the vitamin D levels in their blood, researchers said. “We encourage people with heart disease to discuss vitamin D blood testing and targeted dosing with their health care professionals to meet their individual needs,” lead researcher Heidi May, an epidemiologist at Intermountain Health in Salt Lake City, said in a news release. For the study, researchers recruited 630 adults with heart disease who were treated at Intermountain Medical Center between April 2017 and May 2023. More than 85% of participants began the study with vitamin D levels below 40ng/mL, a level many experts consider too low for best health, researchers said. Participants were around 63 years old on average and 48% had a previous heart attack. One group was assigned to take tailored doses of vitamin D to bring their blood levels up, and the rest received care as normal. “Previous clinical trial research on vitamin D tested the potential impact of the same…  read on >  read on >

MONDAY, Nov. 10, 2025 (Health News) — Millions of Americans who rely on medication for attention deficit hyperactivity disorder (ADHD) may be affected by a new drug recall.  Sun Pharmaceutical Industries has issued a voluntary, nationwide recall for several lots of lisdexamfetamine dimesylate capsules, a generic version of an ADHD treatment prescribed for people over age 6. The U.S. Food and Drug Administration (FDA) classified the recall as a Class II risk. This indicates that using the product “may cause temporary or medically reversible adverse health consequences,” but the probability of serious harm is considered remote. The reason for the recall is a failure in laboratory testing. The FDA said the affected lots of medication did not dissolve as expected during tests. This problem could affect how well the drug works in the body, potentially resulting in patients not getting the intended dose and the full therapeutic benefit. Lisdexamfetamine dimesylate is a widely used drug, with data showing that over nine million prescriptions were dispensed in 2023, according to Newsweek. The recall covers 100-count bottles across a range of doses. The affected lot numbers and expiration dates are: 10 mg: AD42468 (exp. 2/28/2026), AD48705 (exp. 4/30/2026) 20 mg: AD42469 (exp. 2/28/2026), AD48707 (exp. 4/30/2026) 30 mg: AD42470 (exp. 2/28/2026), AD48708 (exp. 4/30/2026) 40 mg: AD48709 (exp. 4/30/2026), AD50894 (exp. 5/31/2026) 50 mg: AD48710 (exp. 4/30/2026),…  read on >  read on >

Affected patients should not stop taking their medication suddenly but should contact their doctor or pharmacy immediately  read on >

Blood tests might be able to tell how badly a concussion has rung a person’s bell, a new study says. Certain brain-related biomarkers in the blood are associated with how bad a teenager’s symptoms will be as they recover from a concussion, researchers reported in the November/December issue of the Journal of Head Trauma Rehabilitation. There are also some significant differences between male and female concussion patients in terms of the markers found in their blood, researchers added. “Our study builds on previous research suggesting that some brain-related markers may provide objective measures of brain injury in teens with concussion,” said lead researcher Mia Pasini, a doctoral student at Johns Hopkins University in Baltimore. “We also identify sex-specific differences in biomarker levels, which may lend insights into the more severe symptoms and longer recovery after concussion in girls and young women,” she added in a news release. For the study, researchers analyzed data on 339 adolescents 11 to 18 years old who had lasting symptoms for up to five weeks following a concussion. The kids’ blood was tested for five proteins and lipids that are released from the brain following a concussion. Results showed that some of these markers did track with the teens’ concussion symptoms. However, boys’ and girls’ markers differed. For example, higher levels of markers related to brain cell damage were associated…  read on >  read on >

Blood tests might be able to tell how badly a concussion has rung a person’s bell, a new study says. Certain brain-related biomarkers in the blood are associated with how bad a teenager’s symptoms will be as they recover from a concussion, researchers reported in the November/December issue of the Journal of Head Trauma Rehabilitation. There are also some significant differences between male and female concussion patients in terms of the markers found in their blood, researchers added. “Our study builds on previous research suggesting that some brain-related markers may provide objective measures of brain injury in teens with concussion,” said lead researcher Mia Pasini, a doctoral student at Johns Hopkins University in Baltimore. “We also identify sex-specific differences in biomarker levels, which may lend insights into the more severe symptoms and longer recovery after concussion in girls and young women,” she added in a news release. For the study, researchers analyzed data on 339 adolescents 11 to 18 years old who had lasting symptoms for up to five weeks following a concussion. The kids’ blood was tested for five proteins and lipids that are released from the brain following a concussion. Results showed that some of these markers did track with the teens’ concussion symptoms. However, boys’ and girls’ markers differed. For example, higher levels of markers related to brain cell damage were associated…  read on >  read on >